Idiopathic CNV | Control | p Value* | |
---|---|---|---|
Hayashi's classification | |||
Type II-A | 7 (15.9%) | 7 (23.3%) | 0.261 |
Type II-B | 5 (11.4%) | 0 (0%) | |
Type III | 9 (20.5%) | 7 (23.3%) | |
Type IV | 23 (52.3%) | 16 (53.3%) | |
Mendrinos’ classification | |||
Stellate | 23 (52.3%) | 15 (50.0%) | 0.150 |
Vertical | 19 (43.2%) | 15 (50.0%) | |
Extending to the fovea | 11 (57.9%) | 3 (10.0%) | |
Without extending to the fovea | 7 (36.8%) | 11 (36.7%) | |
Through the fovea | 1 (5.3%) | 1 (3.3%) | |
Angled | 2 (4.5%) | 0 (0%) | |
Foveal involvement | |||
Foveal | 37 (84.1%) | 11 (36.7%) | <0.0001 |
Non-foveal | 7 (15.9%) | 19 (63.3%) |
*χ2 test.
CNV, choroidal neovascularisation.